Updated guidance on endorsement of FP10MDAs
Updated guidance on the dispensing, endorsement and reimbursement of FP10MDA prescriptions has been issued by the NHS Business Services Authority, following a number of enquiries from pharmacists.
The guidance specifies that, where instalments are being collected daily,
contractors should complete one line on the FP10MDA form for each instalment
and will receive one set of fees per instalment.
Where the prescriber specifies that daily instalments are to be dispensed
in daily dose containers in advance, but will be collected less frequently,
contractors should complete one line for each daily dose container dispensed.
The endorsement should clearly mark the date of supply together with
the instalment date. If the advance instalments are dispensed in one
bottle, only one set of fees should be claimed.
Where the prescriber requests supervised consumption, a fee can be claimed
for both the supervised dose and the remainder taken away in advance.
If the prescriber specifies that these doses must be in individual containers
then a fee can be claimed for each container dispensed. If prescribers
do not specify that instalments should be dispensed in daily dose containers
in advance, only one fee will be payable regardless of whether the instalments
have been dispensed in separate containers.
The Pharmaceutical Services Negotiating Committee has produced examples
of frequently asked questions on this subject, that are available
at its website.
|
The
Pharmaceutical Journal
Acrobat
Reader